Morepen Laboratories Ltd. (MOREPENLAB): Morepen Laboratories Share Price hits fresh 52-week high at Rs 98.51
- August 27, 2026
- Posted by: Harsh Piplani
- Category: News
Morepen Laboratories Share Price opened the session at Rs 97.06, moved to Rs 99.70 and closed at Rs 98.51, up Rs 1.52 or 1.57% from the previous close of Rs 96.99. The move marked a fresh 52-week high and placed Morepen Laboratories Ltd. (MOREPENLAB) firmly in focus in the latest Morepen Laboratories Stock News. The company’s market capitalisation stands at Rs 5,145.29 Cr, which gives investors a clear size reference for today’s Morepen Laboratories Share Price Today update.
The day’s range was narrow on the downside because the low matched the open at Rs 97.06, while the high was also the 52-week peak at Rs 99.70. Turnover stood at Rs 3.4 Cr, which is a factual trading value measure and forms part of the session’s price action. The data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Morepen Laboratories Share Price Live, the event is relevant because the stock printed a fresh yearly high and held above the previous close.
Morepen Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 98.51 |
| Previous Close | Rs 96.99 |
| Today's Move | +Rs 1.52 (+1.57%) |
| Open | Rs 97.06 |
| High | Rs 99.7 |
| Low | Rs 97.06 |
| Turnover | Rs 3.4 crore |
| Market Capitalisation | Rs 5,145.29 crore |
Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 98.51 versus the previous close of Rs 96.99, a rise of 1.57%. The stock opened at Rs 97.06, reached a high of Rs 99.7 and touched a low of Rs 97.06.
Morepen Laboratories Share Price today shows a clear intraday test of the fresh 52-week high. The session started at Rs 97.06, traded between Rs 97.06 and Rs 99.70, and ended at Rs 98.51. That leaves the stock Rs 1.52 above the previous close of Rs 96.99. The latest Morepen Laboratories Share Price Update also shows turnover of Rs 3.4 Cr, which adds context to the day’s trade value without implying any behavioural interpretation.
Because Rs 99.70 is also the fresh 52-week high, the stock’s current quote sits just below that day’s best level. In simple market terms, Morepen Laboratories Stock News today is about a yearly high being set and the closing price remaining close to it. For investors following Morepen Laboratories Share News or Morepen Laboratories NSE and BSE updates, the key factual takeaway is that the stock has established a fresh high on the day and closed above the prior session’s level.
Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,145.29 crore |
| P/E Ratio | 37.82x |
| P/B Ratio | 4.08x |
| ROE | 11.78% |
| ROCE | 15.48% |
| EPS | Rs 2.56 |
| Book Value Per Share | Rs 23.78 |
| Dividend Yield | 0.21% |
Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 37.82x, P/B 4.08x, ROE 11.78%, ROCE 15.48%. These figures provide context only and are not a buy or sell signal.
Morepen Laboratories Ltd. has a market capitalisation of Rs 5145.29 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 37.82x, P/B at 4.08x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 15.48%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.54x, median ROE of 11.91%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 37.82x |
| Benchmark Median P/E | 30.54x |
| Benchmark Average P/E | 47.22x |
| Benchmark P/E Range | 3.19x to 671.51x |
| Company P/B Ratio | 4.08x |
| Benchmark Median P/B | 2.76x |
| Company ROE | 11.78% |
| Benchmark Median ROE | 11.91% |
| Company ROCE | 15.48% |
| Benchmark Median ROCE | 13.75% |
| Company Market Capitalisation | Rs 5,145.29 crore |
| Benchmark Median Market Cap | Rs 623.8 crore |
Morepen Laboratories Ltd. (MOREPENLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 37.82x, which is above the benchmark median of 30.54x, a difference of +23.84%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 11.78%, which is below the benchmark median of 11.91%, a difference of -1.09%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 15.48%, which is above the benchmark median of 13.75%, a difference of +12.58%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| IOL Chemicals And Pharmaceuticals Ltd. | IOLCP | 5,061.88 | 32.49 | 2.93 | 7.9 | 10.65 |
| FDC Ltd. | FDC | 5,600.67 | 19.39 | 2.17 | 12.19 | 16.52 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | 4,577.63 | 94.02 | 15.32 | 21.69 | 27.48 |
| Innova Captab Ltd. | INNOVACAP | 5,952.54 | 37.8 | 5.21 | 13.75 | 15.04 |
| Bliss GVS Pharma Ltd. | BLISSGVS | 5,953.54 | 44.54 | 4.92 | 12.11 | 17.4 |
Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 37.82x compared with the displayed peer median of 37.8x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 12.19% across the companies shown in the table. ROCE stood at 15.48% versus the displayed peer median of 16.52%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 5,145.29 crore. Among the 5 peers shown, 3 have a larger market capitalisation.
Why Investors Are Watching Morepen Laboratories
- Morepen Laboratories Share Price touched a fresh 52-week high of Rs 99.70 and closed at Rs 98.51.
- The stock moved Rs 1.52, or 1.57%, above the previous close of Rs 96.99.
- Market cap stands at Rs 5,145.29 Cr for Morepen Laboratories Share Price Today.
- P/E is 37.82, P/B is 4.08, EPS is Rs 2.56 and book value is Rs 23.78.
- ROE is 11.78% and ROCE is 15.48%, with revenue at Rs 5,701.28 Cr in Jun 2026.
About Morepen Laboratories
Morepen Laboratories Ltd. is part of Healthcare and operates in Pharmaceuticals & Drugs. The supplied data identifies the company by NSE and BSE market tracking through MOREPENLAB. For readers following Morepen Laboratories Share Price, the business context is best understood through the company’s financials, valuation ratios and sector placement rather than broad assumptions.
Morepen Laboratories Stock News today is therefore centred on the fresh 52-week high, the company’s market capitalisation and the supplied financial metrics. This keeps Morepen Laboratories Share Price analysis factual and directly tied to the verified numbers used in the update.
Track Morepen Laboratories Share Price on Univest
Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Morepen Laboratories Share Price on Univest for live updates, key ratios, shareholding pattern, 52-week levels, sector context and company news in one place. Univest also helps readers monitor Morepen Laboratories Share Price Today alongside valuation, returns and benchmark comparisons.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is Morepen Laboratories Share Price today?
Ans. Morepen Laboratories Share Price today is Rs 98.51, up Rs 1.52 or 1.57% from the previous close of Rs 96.99. The stock also touched a fresh 52-week high of Rs 99.70.
Did Morepen Laboratories hit a fresh 52-week high?
Ans. Yes. Morepen Laboratories Share Price reached Rs 99.70 during the session, which is the fresh 52-week high. The stock closed at Rs 98.51 after opening at Rs 97.06. The stock moved 1.57% during the session.
What is the market cap of Morepen Laboratories?
Ans. Morepen Laboratories Market Cap stands at Rs 5,145.29 Cr. Market capitalisation indicates company size and helps place Morepen Laboratories Share Price within its sector and peer set. The company operates in the Healthcare sector.
How expensive is Morepen Laboratories on valuation?
Ans. Morepen Laboratories has a P/E ratio of 37.82 and a P/B ratio of 4.08. In the supplied industry benchmark, P/E is above the median of 30.54 and P/B is above the median of 2.76.
What do the ROE and ROCE numbers show?
Ans. ROE is 11.78% and ROCE is 15.48%. The numbers show that capital employed returns are higher than equity returns on the supplied data, which adds context to Morepen Laboratories Fundamental Analysis.
How do revenue and profit compare in the latest figures?
Ans. Revenue rose to Rs 5,701.28 Cr in Jun 2026 from Rs 4,252.39 Cr in Jun 2025, while net profit increased to Rs 564 Cr from Rs 107.48 Cr. These figures are central to Morepen Laboratories Stock News.
What are the EPS and book value for Morepen Laboratories?
Ans. EPS is Rs 2.56 and book value is Rs 23.78. EPS reflects earnings per share, while book value shows the accounting net worth behind each share in Morepen Laboratories Share Price analysis.
What is the dividend yield of Morepen Laboratories?
Ans. Dividend yield is 0.21%. It is a historical or current payout measure based on the supplied data and should be read alongside Morepen Laboratories Share Price, valuation and profitability metrics.
How does Morepen Laboratories compare with peers?
Ans. Morepen Laboratories’ P/E of 37.82 sits near Innova Captab’s 37.8 and above IOLCP’s 32.49. Its ROCE of 15.48% is stronger than IOLCP and FDC, but below higher-return peers like Supriya Lifescience.
Where can I track Morepen Laboratories Share Price live?
Ans. You can track Morepen Laboratories Share Price on Univest for live price updates, market cap, valuation ratios, sector context and shareholding data. The platform also helps follow Morepen Laboratories Share Price Today and company news.
